Middle East & Africa Lung Cancer Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East & Africa Lung Cancer Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Lung Cancer Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East & Africa Lung Cancer Therapy Market Regional Analysis

6.2 Middle East & Africa Lung Cancer Therapy Market Revenue 2020-2030 (US$ Million)

6.3 Middle East & Africa Lung Cancer Therapy Market Forecast Analysis

7. Middle East & Africa Lung Cancer Therapy Market Analysis – by Therapy Type

7.1 Noninvasive and Minimally Invasive

7.1.1 Overview
7.1.2 Noninvasive and Minimally Invasive: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Middle East & Africa Lung Cancer Therapy Market Analysis – by Indication

8.1 Non-Small Cell Lung Cancer and Small Cell Lung Cancer

8.1.1 Overview
8.1.2 Non-Small Cell Lung Cancer and Small Cell Lung Cancer: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Middle East & Africa Lung Cancer Therapy Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Oncology Clinics

9.2.1 Overview
9.2.2 Oncology Clinics: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Research Centers

9.3.1 Overview
9.3.2 Research Centers: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Middle East & Africa Lung Cancer Therapy Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa

10.2.1 Middle East & Africa Lung Cancer Therapy Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast Analysis – by Country
10.2.1.1 South Africa: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 South Africa: Middle East & Africa Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.1.2 South Africa: Middle East & Africa Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.1.3 South Africa: Middle East & Africa Lung Cancer Therapy Market Breakdown, by End User

10.2.1.2 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.2.2 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.2.3 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market Breakdown, by End User

10.2.1.3 UAE: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 UAE: Middle East & Africa Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.3.2 UAE: Middle East & Africa Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.3.3 UAE: Middle East & Africa Lung Cancer Therapy Market Breakdown, by End User

10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Lung Cancer Therapy Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Bioventus Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Johnson & Johnson

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Medtronic Plc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Merck KGaA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Olympus Corp

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 RF Medical Co Ltd

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Sun Pharmaceutical Industries Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Middle East & Africa Lung Cancer Therapy Market

Analysis - By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), and End User (Hospitals, Oncology Clinics, Research Centers, and Others)